11.32
前日終値:
$11.54
開ける:
$11.5
24時間の取引高:
206.55K
Relative Volume:
0.23
時価総額:
$882.52M
収益:
$1.53B
当期純損益:
$40.23M
株価収益率:
22.64
EPS:
0.5
ネットキャッシュフロー:
$60.93M
1週間 パフォーマンス:
-5.66%
1か月 パフォーマンス:
-10.22%
6か月 パフォーマンス:
-13.58%
1年 パフォーマンス:
-57.03%
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
名前
Integra Lifesciences Holdings Corp
セクター
電話
(609) 275-0500
住所
1100 CAMPUS ROAD, PRINCETON, NJ
IART を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
IART
Integra Lifesciences Holdings Corp
|
11.33 | 898.87M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
107.41 | 189.14B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
BSX
Boston Scientific Corp
|
93.50 | 138.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.79 | 136.52B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.23 | 129.06B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.73 | 48.90B | 5.88B | 1.34B | 799.60M | 2.3489 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-31 | アップグレード | Argus | Hold → Buy |
| 2024-12-02 | 開始されました | Morgan Stanley | Underweight |
| 2024-10-07 | アップグレード | BTIG Research | Sell → Neutral |
| 2024-07-30 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-07-30 | ダウングレード | Citigroup | Neutral → Sell |
| 2024-05-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-05-07 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | アップグレード | Citigroup | Sell → Neutral |
| 2023-12-05 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 開始されました | CL King | Buy |
| 2023-08-24 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | アップグレード | Jefferies | Hold → Buy |
| 2023-06-08 | ダウングレード | Argus | Buy → Hold |
| 2023-05-24 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-05-23 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-25 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2021-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-09-15 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 開始されました | Citigroup | Neutral |
| 2020-04-03 | 開始されました | SunTrust | Buy |
| 2020-01-07 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 開始されました | SunTrust | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-07 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-07-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-01-05 | 再開されました | Cantor Fitzgerald | Neutral |
| 2018-01-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 開始されました | UBS | Buy |
すべてを表示
Integra Lifesciences Holdings Corp (IART) 最新ニュース
Aug Patterns: What is the earnings history of Integra LifeSciences Holdings CorporationQuarterly Growth Report & Growth Focused Investment Plans - baoquankhu1.vn
Earnings Risk: Will Integra LifeSciences Holdings Corporation benefit from geopolitical trends2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What's Going On With Integra LifeSciences Stock Friday?Integra Lifesciences (NASDAQ:IART) - Benzinga
FDA Alert Targets Integra LifeSciences' MediHoney Wound Products - GuruFocus
Aug Decliners: Is Integra LifeSciences Holdings Corporation a cyclical or defensive stockJuly 2025 Retail & Weekly Hot Stock Watchlists - baoquankhu1.vn
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives $15.00 Average PT from Brokerages - Defense World
Integra LifeSciences Holdings C (IART): Investor Outlook With A 17.87% Potential Upside - DirectorsTalk Interviews
Is Integra LifeSciences Holdings Corporation stock a good choice for value investorsJuly 2025 Drop Watch & Consistent Profit Trading Strategies - Улправда
Is Integra LifeSciences Holdings Corporation stock affected by interest rate hikesJuly 2025 Fed Impact & Safe Entry Zone Tips - ulpravda.ru
Bear Alert: Is Integra LifeSciences Holdings Corporation stock affected by interest rate hikesTrade Exit Report & Short-Term Swing Trade Alerts - Улправда
Aug Ideas: How Integra LifeSciences Holdings Corporation (IL3) stock performs in easing cyclesMarket Activity Report & High Accuracy Investment Entry Signals - ulpravda.ru
How buybacks impact Integra LifeSciences Holdings Corporation stock valueMarket Performance Summary & Consistent Profit Alerts - ulpravda.ru
Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 23.41% Potential Upside Amidst Challenges - DirectorsTalk Interviews
Integra LifeSciences to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
3 Reasons to Sell IART and 1 Stock to Buy Instead - Finviz
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer - Quantisnow
At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? - Yahoo Finance
Will Integra LifeSciences Holdings Corporation stock keep outperforming rivalsTrade Exit Summary & Real-Time Volume Triggers - Улправда
What Wall Street predicts for Integra LifeSciences Holdings Corporation stock price - Улправда
How geopolitical tensions affect Integra LifeSciences Holdings Corporation stockMarket Growth Summary & Weekly Return Optimization Plans - Улправда
How Integra LifeSciences Holdings Corporation (IL3) stock reacts to fiscal policiesJuly 2025 Price Swings & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Why Integra LifeSciences Holdings Corporation stock is considered a top pickPortfolio Update Summary & Fast Gaining Stock Reports - DonanımHaber
How supply shortages influence Integra LifeSciences Holdings Corporation (IL3) stockWeekly Profit Summary & Long-Term Capital Growth Ideas - Улправда
Is Integra LifeSciences Holdings Corporation stock resilient to inflation2025 Key Highlights & Community Verified Watchlist Alerts - Улправда
What valuation multiples suggest for Integra LifeSciences Holdings Corporation stockJuly 2025 Price Swings & Low Risk High Reward Trade Ideas - DonanımHaber
Why Integra LifeSciences Holdings Corporation (IL3) stock is favored by hedge fundsWeekly Market Report & Consistent Profit Alerts - DonanımHaber
Why Integra LifeSciences Holdings Corporation stock could outperform in 2025 - Улправда
Will Integra LifeSciences Holdings Corporation stock maintain dividend yield2025 Volume Leaders & High Yield Equity Trading Tips - Улправда
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
Integra LifeSciences Holdings (NASDAQ:IART) Nasdaq Index Procedural Tools - Kalkine Media
Is Integra LifeSciences (IART) Undervalued After Its Recent Share Price Rebound? - simplywall.st
Integra LifeSciences (NASDAQ: IART) adopts renewed CIC severance plan - Stock Titan
Holdings of Integra Lifesciences Holdings Corp (IART) are aligned with the stars - setenews.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketWeekly Trade Summary & Accurate Entry and Exit Point Alerts - Newser
Will Integra LifeSciences Holdings Corporation (IL3) stock test record highs in 2025Forecast Cut & AI Based Buy and Sell Signals - Newser
Adversity is less terrifying than hope: Integra Lifesciences Holdings Corp (IART) - Setenews
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference - The Manila Times
Integra LifeSciences (Nasdaq: IART) slated for Citi 2025 Global Healthcare Conference - Stock Titan
How does Integra Lifesciences Holdings Corp (IART) change from a tortoise to a hare? - Setenews
A Fresh Look at Integra LifeSciences (IART) Valuation After Recent Share Price Volatility - Yahoo Finance
Why Integra LifeSciences Holdings (IART) Is Up 17.7% After Medicare Expands Reimbursement for Skin Substitutes - simplywall.st
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Integra LifeSciences (IART) Welcomes CMS Inclusion of Key Produc - GuruFocus
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access - Finviz
Integra LifeSciences Applauds CMS Ruling on Medicare Payment Schedule Benefiting Skin Substitute Products - Quiver Quantitative
Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know - Yahoo Finance
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know - Barchart.com
How robust is Integra LifeSciences Holdings Corporation (IL3) stock financial positionAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Why Integra LifeSciences Holdings Corporation stock is recommended by analystsEarnings Summary Report & Weekly Stock Performance Updates - newser.com
Integra Lifesciences Holdings Corp (IART) 財務データ
収益
当期純利益
現金流量
EPS
Integra Lifesciences Holdings Corp (IART) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| GRAVES JEFFREY A | Director |
Nov 05 '25 |
Buy |
11.35 |
9,000 |
102,150 |
41,086 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Oct 12 '25 |
Option Exercise |
0.00 |
11,965 |
0 |
25,217 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 11 '25 |
Option Exercise |
0.00 |
2,356 |
0 |
4,391 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
大文字化:
|
ボリューム (24 時間):